Requalification Method for Reentry of Blood Donors Deferred Because of Reactive Test Results for Antibody to Hepatitis B Core Antigen (Anti-HBc): Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 1, 2010
May 15, 2019
277daaf6-6b78-49ea-be56-7a9c5a11d75e
Related Documents
Clinical Considerations for Therapeutic Cancer Vaccines: Guidance for Industry
Guidance DocumentOctober 1, 2011Center for Biologics Evaluation and Research
Potency Tests for Cellular and Gene Therapy Products: Final Guidance for Industry:
Guidance DocumentJanuary 1, 2011Center for Biologics Evaluation and Research
Recommendations for Blood Establishments: Training of Back-Up Personnel, Assessment of Blood Donor Suitability and Reporting Certain Changes to an Approved Application: Guidance for Industry
Guidance DocumentNovember 1, 2010Center for Biologics Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox